Cowden syndrome (CS) is an autosomal dominant inherited syndrome chara
cterised by hamartoma development in multiple organs and a risk of bre
ast, thyroid and other cancers. The susceptibility gene for this syndr
ome was mapped to 10q22-23. Subsequently, germline mutations in PTEN,
which encodes a dual specificity phosphatase, were found in individual
s and families with CS. With the identification of the CS susceptibili
ty gene, DNA-based predictive testing may be offered in theory. Somati
c mutations in PTEN have been described in sporadic thyroid tumors, en
dometrial carcinomas, prostate carcinomas and glioblastoma multiforme.
Although initial analyses suggest that the presence of somatic PTEN a
lterations appear to be associated with more advanced disease in carci
nomas of the prostate and brain, this does not appear to be the case i
n epithelial thyroid tumors.